8-K: Scilex Holding Company Announces 1-for-35 Reverse Stock Split to Regain Nasdaq Compliance
Press Release
Scilex Holding Company will implement a 1-for-35 reverse stock split, effective April 15, 2025, to meet Nasdaq's minimum bid price requirement.
Summary
- Scilex Holding Company announced a 1-for-35 reverse stock split of its common stock.
- The reverse stock split will be effective as of 12:01 a.m. Eastern Time on April 15, 2025.
- Trading on a split-adjusted basis will begin at the market opening on April 15, 2025.
- The company's stock will continue to trade on the Nasdaq Capital Market under the symbol SCLX, with a new CUSIP number (80880W 205).
- The primary goal of the reverse stock split is to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share.
- The reverse stock split will not alter the authorized number of shares of Scilex's common stock.
- Stockholders who would have received fractional shares will instead receive a cash payment based on the closing sales price on April 14, 2025.
- The reverse stock split will also apply to common stock issuable upon the exercise or conversion of outstanding warrants, Series A Preferred Stock, convertible notes, and stock options, with corresponding adjustments to exercise and conversion prices.
- The reverse stock split will reduce the number of issued and outstanding shares from approximately 243 million to approximately 6.9 million.
- Scilex's stockholders approved the reverse stock split at a special meeting on March 19, 2025, granting the board discretion to select a ratio between 1-for-14 and 1-for-50.
- The board approved the 1-for-35 ratio on April 3, 2025.
- Continental Stock Transfer & Trust Company is the exchange agent and paying agent for the reverse stock split.
Sentiment
Score: 5
Explanation: The announcement is neutral. While the reverse stock split is a necessary step to maintain Nasdaq listing, it also reflects underlying concerns about the company's stock price.
Positives
- The reverse stock split aims to ensure continued listing on the Nasdaq Capital Market, which could improve investor confidence.
- The company is addressing a compliance issue with the Nasdaq minimum bid price requirement.
- Stockholders will receive cash in lieu of fractional shares, providing them with immediate value.
Negatives
- The reverse stock split is being implemented to avoid delisting, which may be perceived negatively by investors.
- The reverse stock split reduces the number of outstanding shares, which could increase volatility.
Risks
- There is no guarantee that the reverse stock split will successfully maintain compliance with Nasdaq listing requirements.
- The company's stock price may continue to decline, even after the reverse stock split.
- The reverse stock split could negatively impact investor sentiment.
Future Outlook
Scilex aims to regain compliance with Nasdaq's minimum bid price requirement through the reverse stock split.
Industry Context
Reverse stock splits are often used by companies facing delisting from major exchanges to artificially increase their stock price and meet minimum listing requirements.
Comparison to Industry Standards
- Many companies in the pharmaceutical and biotech industries have used reverse stock splits to maintain exchange listings.
- For example, companies like BioDelivery Sciences International and Aeterna Zentaris have previously implemented reverse stock splits to comply with Nasdaq's minimum bid price rule.
- The success of a reverse stock split in maintaining compliance and improving investor confidence varies depending on the company's underlying financial health and future prospects.
Stakeholder Impact
- Shareholders will be impacted by the reduced number of shares and potential cash payments in lieu of fractional shares.
- The company's employees may be affected by the potential impact on the company's stock price and overall financial stability.
Next Steps
- The reverse stock split will be effective on April 15, 2025.
- Scilex's common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on April 15, 2025.
- Continental Stock Transfer & Trust Company will provide instructions to stockholders with certificates regarding the exchange process.
Key Dates
| Date | Description |
|---|---|
| March 19, 2025 | Scilex's stockholders approved the reverse stock split. |
| April 3, 2025 | Scilex's board of directors approved the reverse stock split at a ratio of 1-for-35. |
| April 11, 2025 | Date of the press release announcing the reverse stock split. |
| April 14, 2025 | Date used to determine the closing sales price for cash payments in lieu of fractional shares. |
| April 15, 2025 | Effective date of the 1-for-35 reverse stock split and the start of trading on a split-adjusted basis. |
Keywords
reverse stock split, Nasdaq, compliance, SCLX, Scilex Holding Company, minimum bid price, stock split
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.